Vero Biotech Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VERO BIOTECH, and when can generic versions of VERO BIOTECH drugs launch?
VERO BIOTECH has one approved drug.
There are twenty-four US patents protecting VERO BIOTECH drugs.
There are fifty-nine patent family members on VERO BIOTECH drugs in five countries and two supplementary protection certificates in two countries.
Drugs and US Patents for Vero Biotech
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 9,701,538 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 8,821,801 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 10,814,092 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 11,291,793 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 11,554,241 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 9,956,373 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | 11,672,938 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Vero Biotech
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | 6,758,214 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Vero Biotech Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 7029497 | ⤷ Try a Trial |
Japan | 2015013118 | ⤷ Try a Trial |
European Patent Office | 4180078 | ⤷ Try a Trial |
Japan | 2020195783 | ⤷ Try a Trial |
Australia | 2009209181 | ⤷ Try a Trial |
Australia | 2022256079 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2008118360 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Vero Biotech Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0786264 | SPC/GB08/019 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: NITRIC OXIDE (NO); REGISTERED: UK EU/1/01/194/001 20010801 |
0560928 | 2002C/003 | Belgium | ⤷ Try a Trial | PRODUCT NAME: NITRIC OXIDE; REGISTRATION NO/DATE: EU/1/01/194/001 20010801 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.